Miyagi, Mariana Yasue Saito 
; Faria, Rafael de Oliveira; Lameu, Claudiana ; Souza, Gabriel Batista de; Tagami, Tatsuaki; Ozeki, Tetsuya; Bezzon, Vinícius Danilo Nonato ; Yukuyama, Megumi Nishitani ; Bou-Chacra, Nadia Araci ; Araujo, Gabriel Lima Barros de
Fonte: International Journal of Pharmaceutics. Unidade: FCF
Assuntos: QUIMIOTERAPIA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAGI, Mariana Yasue Saito et al. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, v. 644, p. 1-13 art. 123324, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123324. Acesso em: 08 jul. 2024.APA
Miyagi, M. Y. S., Faria, R. de O., Lameu, C., Souza, G. B. de, Tagami, T., Ozeki, T., et al. (2023). Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, 644, 1-13 art. 123324. doi:10.1016/j.ijpharm.2023.123324NLM
Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324Vancouver
Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 jul. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
